Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.
- NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_assertion description "[Adel55-cHSF1 treatment also showed higher efficacy in diminishing progression of the secondary tumor focus than Adel55-HSP70 or Adel55-HSP90 treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.
- NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_assertion evidence source_evidence_literature NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.
- NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_assertion SIO_000772 22613625 NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.
- NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_assertion wasDerivedFrom befree-20140225 NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.
- NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_assertion wasGeneratedBy ECO_0000203 NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP931679.RAHm8kH25Sjg-y9D2BmQH9LzuCMkhVNn3tlhls8H_jLtY130_provenance.